Lipaglyn (Saroglitazar) for Treating Hypertriglycerdemia in Type II Diabetes

Lipaglyn obtained the DCGI approval for treating diabetic dyslipidemia in type II diabetes in June 2013.



  • Lipaglyn
  • Lipaglyn is available in tablets of 4mg strength.
  • 3l-Image-Lipaglyn
  • 4l-Image-Lipaglyn